BACKGROUND: Steatotic livers are vulnerable to the deleterious effects of ischaemia-reperfusion injury (IRI) that occur after hepatic surgery. Ischaemic preconditioning (IPC) has been shown to abrogate the effects of IRI in patients undergoing hepatic surgery. Experimental studies have suggested that IPC may be beneficial in steatotic livers subjected to IRI. OBJECTIVE: The aim of this systematic review was to evaluate the effects of IPC on steatotic livers following hepatic IRI in experimental models. METHODS: An electronic search of the OVID Medline and EMBASE databases was performed to identify studies that reported clinically relevant outcomes in animal models of hepatic steatosis subjected to IPC and IRI. RESULTS: A total of 1093 articles were identified, of which 18 met the inclusion criteria. There was considerable heterogeneity in the type of animal model, and duration and type of IRI. Increased macrovesicular steatosis (> 30%) was associated with a poor outcome following IRI. Ischaemic preconditioning was found to be beneficial in > 30% steatotic livers and provided for decreased histological damage, improved liver function findings and increased survival. CONCLUSIONS: Experimental evidence supports the use of IPC in steatotic livers undergoing IRI. These findings may be applicable to patients undergoing liver surgery. However, clinical studies are required to validate the efficacy of IPC in this setting.
BACKGROUND: Steatotic livers are vulnerable to the deleterious effects of ischaemia-reperfusion injury (IRI) that occur after hepatic surgery. Ischaemic preconditioning (IPC) has been shown to abrogate the effects of IRI in patients undergoing hepatic surgery. Experimental studies have suggested that IPC may be beneficial in steatotic livers subjected to IRI. OBJECTIVE: The aim of this systematic review was to evaluate the effects of IPC on steatotic livers following hepatic IRI in experimental models. METHODS: An electronic search of the OVID Medline and EMBASE databases was performed to identify studies that reported clinically relevant outcomes in animal models of hepatic steatosis subjected to IPC and IRI. RESULTS: A total of 1093 articles were identified, of which 18 met the inclusion criteria. There was considerable heterogeneity in the type of animal model, and duration and type of IRI. Increased macrovesicular steatosis (> 30%) was associated with a poor outcome following IRI. Ischaemic preconditioning was found to be beneficial in > 30% steatotic livers and provided for decreased histological damage, improved liver function findings and increased survival. CONCLUSIONS: Experimental evidence supports the use of IPC in steatotic livers undergoing IRI. These findings may be applicable to patients undergoing liver surgery. However, clinical studies are required to validate the efficacy of IPC in this setting.
Authors: Claus U Niemann; Ryutaro Hirose; Tao Liu; Matthias Behrends; Jaimi L Brown; Douglas F Kominsky; John P Roberts; Natalie Serkova Journal: Anesth Analg Date: 2005-12 Impact factor: 5.108
Authors: Araní Casillas-Ramírez; Izabel Alfany-Fernández; Marta Massip-Salcedo; M Emília Juan; Joana M Planas; Anna Serafín; Mercè Pallàs; Antoni Rimola; Juan Rodés; Carmen Peralta Journal: J Pharmacol Exp Ther Date: 2011-04-12 Impact factor: 4.030
Authors: Austin L Spitzer; Oliver B Lao; André A S Dick; Ramasamy Bakthavatsalam; Jeffrey B Halldorson; Matthew M Yeh; Melissa P Upton; Jorge D Reyes; James D Perkins Journal: Liver Transpl Date: 2010-07 Impact factor: 5.799
Authors: R J Ploeg; A M D'Alessandro; S J Knechtle; M D Stegall; J D Pirsch; R M Hoffmann; T Sasaki; H W Sollinger; F O Belzer; M Kalayoglu Journal: Transplantation Date: 1993-04 Impact factor: 4.939
Authors: Anna Serafín; Joan Roselló-Catafau; Neus Prats; Emilio Gelpí; Joan Rodés; Carmen Peralta Journal: Hepatology Date: 2004-03 Impact factor: 17.425
Authors: D Degli Esposti; M Sebagh; P Pham; M Reffas; C Poüs; C Brenner; D Azoulay; A Lemoine Journal: Cell Death Dis Date: 2011-01-13 Impact factor: 8.469
Authors: Kimberley E Wever; Theo P Menting; Maroeska Rovers; J Adam van der Vliet; Gerard A Rongen; Rosalinde Masereeuw; Merel Ritskes-Hoitinga; Carlijn R Hooijmans; Michiel Warlé Journal: PLoS One Date: 2012-02-28 Impact factor: 3.240
Authors: Ricardo C Gehrau; Valeria R Mas; Catherine I Dumur; Jihee L Suh; Ashish K Sharma; Helen P Cathro; Daniel G Maluf Journal: Transplantation Date: 2015-12 Impact factor: 4.939
Authors: Michael Jj Chu; Rakesh Premkumar; Anthony Jr Hickey; Yannan Jiang; Brett Delahunt; Anthony Rj Phillips; Adam Sjr Bartlett Journal: World J Gastroenterol Date: 2016-05-21 Impact factor: 5.742
Authors: Michael J J Chu; Ryash Vather; Anthony J R Hickey; Anthony R J Phillips; Adam S J R Bartlett Journal: Biomed Res Int Date: 2015-02-10 Impact factor: 3.411